Summary & Overview
CPT 92960: Elective External Cardioversion for Cardiac Arrhythmias
CPT code 92960 represents elective external cardioversion, a widely used cardiovascular procedure to treat arrhythmias by restoring normal heart rhythm through electrical conversion. This code is significant in national healthcare delivery, as it addresses common cardiac conditions such as atrial fibrillation and supraventricular tachycardia. The procedure is typically performed in outpatient hospital settings, making it accessible for a broad patient population.
Major payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, Medicare, and UnitedHealthcare. The publication provides a comprehensive overview of clinical indications, billing benchmarks, and policy updates relevant to 92960. Readers will gain insight into payer coverage, typical sites of service, and associated clinical contexts. Additionally, the summary highlights related codes and modifiers, offering a clear understanding of how this procedure fits within the broader landscape of cardiovascular care and medical billing. This resource is designed to inform healthcare professionals, administrators, and policy analysts about the current standards and practices for elective external cardioversion.
CPT Code Overview
CPT code 92960 describes elective external cardioversion, a procedure used to restore normal heart rhythm in patients experiencing certain types of arrhythmias. This service is classified under cardiovascular procedures and is typically performed in an outpatient hospital setting (Place of Service 22). The procedure involves delivering a controlled electrical shock to the heart to convert an abnormal rhythm to a normal sinus rhythm. Elective external cardioversion is commonly utilized for arrhythmias such as atrial fibrillation or supraventricular tachycardia, providing a critical intervention for patients with rhythm disturbances.
Clinical & Coding Specifications
Clinical Context
A patient presents to the outpatient hospital with symptoms suggestive of an arrhythmia, such as palpitations, dizziness, or syncope. After evaluation, the patient is diagnosed with a cardiac arrhythmia, such as atrial fibrillation or supraventricular tachycardia. The care team determines that elective external electrical cardioversion is indicated to restore normal sinus rhythm. The procedure is performed by a cardiovascular specialist, typically under sedation, using external electrodes to deliver a controlled electrical shock. Post-procedure, the patient is monitored for rhythm stability and potential complications before discharge.
Coding Specifications
- Modifier
63: Used when the procedure is performed on infants weighing less than 4 kg. This modifier indicates the increased complexity and risk associated with performing cardioversion on very small pediatric patients.
| Modifier Code | Description |
|---|---|
63 | Procedure performed on infants less than 4 kg |
- Provider Taxonomies:
| Taxonomy Code | Specialty |
|---|---|
207RC0000X | Cardiovascular Disease Physician |
207RR0000X | Interventional Cardiology Physician |
207RC0200X | Clinical Cardiac Electrophysiology Physician |
207R00000X | Internal Medicine Physician |
208600000X | Surgery Physician |
These specialties represent providers qualified to perform elective external cardioversion.
Related Diagnoses
-
I48.91- Unspecified atrial fibrillation- Represents patients with atrial fibrillation where the specific type is not documented. Common indication for elective cardioversion.
-
I48.0- Paroxysmal atrial fibrillation- Refers to intermittent episodes of atrial fibrillation. Elective cardioversion is often used to restore sinus rhythm.
-
I47.1- Supraventricular tachycardia- Includes arrhythmias originating above the ventricles. External cardioversion may be indicated for acute management.
-
I49.01- Ventricular fibrillation- Life-threatening arrhythmia; while external cardioversion may be used, this is typically an emergency rather than elective.
-
I49.9- Cardiac arrhythmia, unspecified- Used when the specific arrhythmia type is not identified. Cardioversion may be considered if clinically appropriate.
-
R00.1- Bradycardia, unspecified- Represents slow heart rhythms. While not a typical indication for cardioversion, may be relevant in certain clinical scenarios.
Related CPT Codes
-
93000- Electrocardiogram, routine ECG- Used to assess cardiac rhythm before and after cardioversion. Commonly performed in conjunction with
92960.
- Used to assess cardiac rhythm before and after cardioversion. Commonly performed in conjunction with
-
93224- Holter monitor, up to 48 hours- Used for extended rhythm monitoring prior to or following cardioversion to evaluate arrhythmia burden.
-
93653- Comprehensive electrophysiologic evaluation- May be performed to assess arrhythmia mechanisms or guide therapy decisions before considering cardioversion.
-
92950- Cardiopulmonary resuscitation (CPR)- Used in emergency situations; not typically performed with elective cardioversion but related in the context of cardiac emergencies.
-
92961- Cardioversion, internal (invasive)- Alternative to
92960for cases requiring internal electrical conversion. Not performed externally.
- Alternative to
-
93799- Unlisted cardiovascular service or procedure- Used when a cardiovascular service does not have a specific CPT code. May be relevant for unique or uncommon procedures related to arrhythmia management.
National Reimbursement Benchmarks
National mean rates for CPT code 92960 show that Medicare reimbursement ($159.69) is significantly lower than the average commercial rate represented by BUCA ($198.31). Commercial payers such as UnitedHealth Group ($262.83) and Cigna ($245.00) offer notably higher mean rates compared to both Medicare and BUCA.
Rate dispersion, measured by the difference between the 75th and 25th percentiles, varies across payers. Medicare exhibits the tightest range ($14.00), indicating less variability in payment rates. In contrast, UnitedHealth Group has the widest dispersion ($144.00), followed by Cigna ($120.50), reflecting greater variability in commercial reimbursement. Blue Cross Blue Shield and BUCA also show moderate dispersion ($89.50 and $99.73, respectively).
The table and chart below present a detailed breakdown of national benchmarks for each payer, including mean rates and percentile values.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.